Literature DB >> 43258

Lisuride hydrogen maleate: an ergoline with beta-adrenergic antagonist activity.

T Cote, M Munemura, J Kebabian.   

Abstract

Lisuride hydrogen maleate is identified as a potent beta-adrenergic antagonist using a hormone-sensitive adenylate cyclase system and [3H]dihydroalprenolol binding in cell free homogenates of rabbit cerebellum. Lisuride and two other ergolines, lergotrile and bromocriptine, and the phenothiazine, fluphenazine, all interact with spiroperidol binding sites (dopamine receptors) in the anterior pituitary; however, among these compounds lisuride is unique in its ability to antagonize the beta-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 43258     DOI: 10.1016/0014-2999(79)90295-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Comparative evaluation of lisuride and terguride, ergot alkaloid derivatives, on the field-stimulated vas deferens of mouse.

Authors:  M R Carratù; A DeSerio; D Mitolo-Chieppa; F Federico
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain.

Authors:  G P Reynolds; P Riederer
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

3.  Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.

Authors:  H Fink; R Morgenstern
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.